Mercaptor develops drugs to treat damage, dysfunction, and degeneration of the brain. Our molecules, called captons, are designed to reduce acute and progressive pathologies initiated by neuronal injury. Captons combine three complementary neuroprotective activities into a single small-molecule agent.

The approach is investigational and without precedent. It also promises significant improvements in the performance of a variety of drugs. If capton dosage is metered and delimited by the pathogenic species it is designed to treat, interference in healthy tissue function will be minimized.



We started Mercaptor Discoveries because science moves forward on unsteady feet, relying on a tiny amount of fortuity mixed into a vast trough of human frailty. Good luck cannot be ignored. Much of our time and effort has revolved around sulfur biochemistry. One day, we tripped over something unexpected, a result lying outside of our assumptions. Avoiding the false comfort of certainty, honest scientists sometimes catch a glimpse into the infinite Universe. These rare insights are more likely to help move the world forward than countless years spent trying to prove expectations. The opportunity obliges us to take responsibility for the continued development of what we have learned.

Read More About Mercaptor's Origins

Read all about our exciting discovery of captons.

Mercaptor In The News: